NCT00091143
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,768 public trials
494 recruiting studies
Neuroendocrine Tumors trial results
NCT00014092
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Saint Francis Memorial Hospital San Francisco, California, United States
- John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States
NCT00003229
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
- Cancer Center, University of Virginia HSC Charlottesville, Virginia, United States
NCT00004244
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
Completed
Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
NCT00104845
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00288041
- Conditions
- Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00512889
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00003665
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States
Completed
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
NCT00068783
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States